Numinus Wellness (LKYSF) Stock Price, News & Analysis

Numinus Wellness, Inc. operates as a Canadian health care company empowering healing and wellness through the development and delivery of safe, evidence-based psychedelic-assisted therapies for mental illness, substance abuse and trauma. The Numinus model comprises psychedelic production, clinical research and clinical care, with a Health Canada-licenced research facility, seasoned medical team and growing network of clinics. The company's licence allows for a range of research activities and import, export and distribution of psychedelic substances including DMT, ketamine, LSD, MDMA, mescaline, psilocybin, psilocin. It operates through the following segments: Salvation Botanicals, Numinus Health and Salvation Bioscience. The Salvation Botanicals segment engages in psychedelic substance research, developing intellectual property while offering analytics services for revenue generation. Its laboratory provides services including cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics. The Numinus Health segment operates the wellness centre where professional therapists and health professionals use supportive therapies and